RE: Moving up21 Oct 2022 11:26
Nothing is straightforward with GDR butAIHL and the stroke test will be monumental to the sp , but it will take time , as in years . In saying that the NICE approval will be the catylist to the re rate we all want from the sp as the will be the kickstart for sales not just in the UK but also Europe and the rest of the world . It is possible that takeover offers will come in when sales of AIHL start in the U.S. , possibly sooner . My big worry is that because we have been under water for so long that a measly offer will be accepted without the full potential being realised . Once AIHL is up and running fully over the U.S. And EU The yearly revenue is expected to be about £70m a year , those figures quoted do not include the rest of the world , add the stroke test and then any P/E ratio between 5 and 15 then you get an idea of the true value . Just to add this my guess only but having read some posts lately there are others who seem it as a similar value . Might as well put my neck on the block while I am at it even though I will be slaughtered for it IF the sales of the tests were to run there full course in 4-5 years the sp could IMO reach £8plus , depending on any dilutions along the way so any offers below £3 in 2 years or so I feel will be poor . Don't worry hard hat is already on for the bashing I will get but this is how is we it could easily go .